Risk factors for macrophage activation syndrome in systemic juvenile idiopathic arthritis: a systematic review and
Shihao Li1,2,3, Xin Wu1,2,3, Shuolan Jing1,2,3
1Division of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu, China.
Background:
Macrophage activation syndrome (MAS) is among the most life-threatening complications of systemic juvenile idiopathic arthritis (sJIA). Early identification of risk factors is critical for reducing mortality. However, existing evidence is markedly heterogeneous and lacks quantified, comparable, and clinically translatable conclusions.
Methods:
We systematically searched PubMed, Web of Science, EMBASE, and Chinese databases, including China national knowledge infrastructure (CNKI), Wanfang, VIP, and Chinese biomedical literature database (CBM), from inception to 1 July 2025, for case-control studies investigating risk factors for MAS in sJIA. Two investigators independently screened studies, extracted data, and assessed study quality. Meta-analyses were performed using RevMan 5.3 and Stata 16.0.
Result:
A total of 10 studies involving 1,936 patients were included, comprising 643 cases and 1,293 controls. Meta-analysis showed that central nervous system (CNS) involvement, hypofibrinogenemia, markedly elevated ferritin levels, and leukopenia were significantly associated with MAS in sJIA, with odds ratios (95% confidence intervals) of 4.30 (2.13-8.65), 4.03 (2.87-5.65), 8.28 (5.66-12.10), and 5.98 (2.80-12.75), respectively.
Conclusion:
CNS involvement, hypofibrinogenemia, hyperferritinemia, and leukopenia are core risk factors for MAS in patients with sJIA.
Systematic Review Registration:
PROSPERO CRD420251108082.
Insights
Identifying risk factors for macrophage activation syndrome (MAS) in systemic juvenile idiopathic arthritis (sJIA) is crucial. Central nervous system involvement, low fibrinogen, high ferritin, and leukopenia are key indicators for MAS in sJIA patients.
Area of Science:
- Rheumatology
- Pediatrics
- Critical Care Medicine
Background:
- Macrophage activation syndrome (MAS) is a life-threatening complication of systemic juvenile idiopathic arthritis (sJIA).
- Early identification of MAS risk factors is critical for reducing mortality in sJIA patients.
- Existing evidence on MAS risk factors is heterogeneous and lacks clinically translatable conclusions.
Purpose of the Study:
- To systematically identify and quantify risk factors for MAS in sJIA.
- To provide clinically relevant insights for early MAS detection and management.
Main Methods:
- Systematic literature search of multiple databases (PubMed, Web of Science, EMBASE, CNKI, Wanfang, VIP, CBM) up to July 1, 2025.
- Inclusion of case-control studies investigating MAS risk factors in sJIA.
- Meta-analysis using RevMan 5.3 and Stata 16.0.
Main Results:
- Ten studies involving 1,936 patients (643 cases, 1,293 controls) were included.
- Significant associations found for central nervous system (CNS) involvement (OR 4.30), hypofibrinogenemia (OR 4.03), hyperferritinemia (OR 8.28), and leukopenia (OR 5.98).
- These factors demonstrated substantial odds ratios, indicating strong associations with MAS in sJIA.
Conclusions:
- Central nervous system involvement, hypofibrinogenemia, hyperferritinemia, and leukopenia are core risk factors for MAS in sJIA.
- These identified factors are crucial for early risk assessment and timely intervention in sJIA patients.
- The findings offer quantified and comparable conclusions to guide clinical practice.
More Related Videos
09:18Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
Published on: February 24, 2023
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Related Concept Videos
The JAK-STAT Signaling Pathway
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
